Ocugen, Inc.
OCGN
$0.689
$0.04186.46%
| Weiss Ratings | OCGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | OCGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | OCGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.29 | |||
| Price History | OCGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 8.10% | |||
| 30-Day Total Return | -0.98% | |||
| 60-Day Total Return | -22.97% | |||
| 90-Day Total Return | -21.13% | |||
| Year to Date Total Return | -23.44% | |||
| 1-Year Total Return | -50.07% | |||
| 2-Year Total Return | -20.11% | |||
| 3-Year Total Return | -80.03% | |||
| 5-Year Total Return | 146.07% | |||
| 52-Week High % Change | -68.88% | |||
| 52-Week Low % Change | 25.67% | |||
| Price | OCGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.08 | |||
| 52-Week Low Price | $0.52 | |||
| 52-Week Low Price (Date) | Mar 18, 2025 | |||
| 52-Week High Price (Date) | Apr 08, 2024 | |||
| Valuation | OCGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 188.99M | |||
| Enterprise Value | 162.98M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.20 | |||
| Earnings Per Share Growth | -24.14% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 46.56 | |||
| Price/Book (Q) | 6.36 | |||
| Enterprise Value/Revenue (TTM) | 40.19 | |||
| Price | $0.69 | |||
| Enterprise Value/EBITDA (TTM) | -3.09 | |||
| Enterprise Value/EBIT | -2.98 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | OCGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 290.92M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | OCGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 484 328 4701 | |||
| Address | 11 Great Valley Parkway Malvern, PA 19355 | |||
| Website | www.ocugen.com | |||
| Country | United States | |||
| Year Founded | 2013 | |||
| Profitability | OCGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1,350.35% | |||
| Profit Margin | -1,333.02% | |||
| Management Effectiveness | OCGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -46.57% | |||
| Return on Equity | -- | |||
| Income Statement | OCGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.06M | |||
| Total Revenue (TTM) | 4.06M | |||
| Revenue Per Share | $0.01 | |||
| Gross Profit (TTM) | -28.07M | |||
| EBITDA (TTM) | -52.79M | |||
| EBIT (TTM) | -54.76M | |||
| Net Income (TTM) | -54.05M | |||
| Net Income Avl. to Common (TTM) | -54.05M | |||
| Total Revenue Growth (Q YOY) | -45.78% | |||
| Earnings Growth (Q YOY) | -26.53% | |||
| EPS Diluted (TTM) | -0.20 | |||
| EPS Diluted Growth (Q YOY) | -11.71% | |||
| Balance Sheet | OCGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 58.51M | |||
| Cash Per Share (Q) | $0.20 | |||
| Total Current Assets (Q) | 61.68M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 29.63M | |||
| Current Ratio (Q) | 2.857 | |||
| Book Value Per Share (Q) | $0.10 | |||
| Total Assets (Q) | 82.44M | |||
| Total Current Liabilities (Q) | 21.59M | |||
| Total Debt (Q) | 32.50M | |||
| Total Liabilities (Q) | 52.81M | |||
| Total Common Equity (Q) | 29.63M | |||
| Cash Flow | OCGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -3.39M | |||
| Cash from Financing (TTM) | 64.86M | |||
| Net Change in Cash (TTM) | 19.36M | |||
| Levered Free Cash Flow (TTM) | -24.64M | |||
| Cash from Operations (TTM) | -42.14M | |||
